18:11 IST
BSE
Management Change
Kilitch Drugs(I) Management Change
Kilitch Drugs (India) Limited has re-appointed Arivind Kumar & Co. as its Cost Auditor for a 12-month term.
Kilitch Drugs(I) Ltd
- Share price
- ₹256.25
- Market cap
- ₹895.9 Cr
- Revenue (annual)
- ₹235.5 Cr
- Net profit (annual)
- ₹30.17 Cr
- P/E (TTM)
- 29.8×Sector 47.3×
- Promoter holding
- 63.77%+0.00% QoQ
- FII holding
- 0.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 2Board Meeting Date 2Annual General Meeting 2Management Change 1Financial Results 1Annual Report 1
Time
1 announcement with these filters